tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Kissei Pharmaceutical’s Promising Phase III Study on Spinocerebellar Degeneration
PremiumCompany AnnouncementsKissei Pharmaceutical’s Promising Phase III Study on Spinocerebellar Degeneration
1M ago
Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment
Premium
Company Announcements
Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment
1M ago
Kissei Pharmaceutical’s Avacopan Study: A Potential Game-Changer for Autoimmune Treatments
Premium
Company Announcements
Kissei Pharmaceutical’s Avacopan Study: A Potential Game-Changer for Autoimmune Treatments
1M ago
Kissei Pharmaceutical Completes Sale of Investment Securities
PremiumCompany AnnouncementsKissei Pharmaceutical Completes Sale of Investment Securities
2M ago
Kissei Pharmaceutical Secures Licensing for TED Treatments in Japan
Premium
Company Announcements
Kissei Pharmaceutical Secures Licensing for TED Treatments in Japan
4M ago
Kissei Pharmaceutical Revises Financial Forecast and Records Extraordinary Income
Premium
Company Announcements
Kissei Pharmaceutical Revises Financial Forecast and Records Extraordinary Income
4M ago
Kissei Pharmaceutical’s Phase III Study on KPS-0373: A Potential Breakthrough in Spinocerebellar Degeneration Treatment
PremiumCompany AnnouncementsKissei Pharmaceutical’s Phase III Study on KPS-0373: A Potential Breakthrough in Spinocerebellar Degeneration Treatment
5M ago
Kissei Pharmaceutical Introduces Restricted Stock Compensation System
Premium
Company Announcements
Kissei Pharmaceutical Introduces Restricted Stock Compensation System
5M ago
Kissei Pharmaceutical Reports Strong Fiscal 2024 Performance with Strategic Market Expansion
Premium
Company Announcements
Kissei Pharmaceutical Reports Strong Fiscal 2024 Performance with Strategic Market Expansion
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100